We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ATLAS Biolabs is Awarded Certified Service Provider Accreditation from Affymetrix for DMET Analysis

Product News   Sep 25, 2012

 
ATLAS Biolabs is Awarded Certified Service Provider Accreditation from Affymetrix for DMET Analysis
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published

Product News

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

READ MORE

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE